THY1 and nasopharyngeal carcinoma: Furthermore, induction of CD90 expression in nasopharyngeal carcinoma and ovarian cell lines leads to inhibition of tumor growth in vitro and in vivo, respectively (Abeysinghe et al., 2003; Lung et al., 2005).